Department of Physiology and Biophysics, Virginia Commonwealth University, Richmond, VA 23298-0551, USA.
Cardiovasc Res. 2010 Oct 1;88(1):93-100. doi: 10.1093/cvr/cvq125. Epub 2010 May 5.
We assessed regulation of volume-sensitive Cl(-) current (I(Cl,swell)) by endothelin-1 (ET-1) and characterized the signalling pathway responsible for its activation in rabbit atrial and ventricular myocytes.
ET-1 elicited I(Cl,swell) under isosmotic conditions. Outwardly rectified Cl(-) current was blocked by the I(Cl,swell)-selective inhibitor DCPIB or osmotic shrinkage and involved ET(A) but not ET(B) receptors. ET-1-induced current was abolished by inhibiting epidermal growth factor receptor (EGFR) kinase or phosphoinositide-3-kinase (PI-3K), indicating that these kinases were downstream. Regarding upstream events, activation of I(Cl,swell) by osmotic swelling or angiotensin II (AngII) was suppressed by ET(A) blockade, whereas AngII AT(1) receptor blockade failed to alter ET-1-induced current. Reactive oxygen species (ROS) produced by NADPH oxidase (NOX) stimulate I(Cl,swell). As expected, blockade of NOX suppressed ET-1-induced I(Cl,swell), but blockade of mitochondrial ROS production with rotenone also suppressed I(Cl,swell). I(Cl,swell) was activated by augmenting complex III ROS production with antimycin A or diazoxide; in this case, I(Cl,swell) was insensitive to NOX inhibitors, indicating that mitochondria were downstream from NOX. ROS generation in HL-1 cardiomyocytes measured by flow cytometry confirmed the electrophysiological findings. ET-1-induced ROS production was inhibited by blocking either NOX or mitochondrial complex I, whereas complex III-induced ROS production was insensitive to NOX blockade.
ET-1-ET(A) signalling activated I(Cl,swell) via EGFR kinase, PI-3K, and NOX ROS production, which triggered mitochondrial ROS production. ET(A) receptors were downstream effectors when I(Cl,swell) was elicited by osmotic swelling or AngII. These data suggest that ET-1-induced ROS-dependent I(Cl,swell) is likely to participate in multiple physiological and pathophysiological processes.
我们评估了内皮素-1(ET-1)对容量敏感氯离子电流(I(Cl,swell))的调节作用,并对其在兔心房和心室肌细胞中激活的信号通路进行了特征描述。
ET-1 在等渗条件下引发 I(Cl,swell)。通过 I(Cl,swell)选择性抑制剂 DCPIB 或渗透收缩抑制外向整流氯离子电流,该电流涉及 ET(A)但不涉及 ET(B)受体。表皮生长因子受体(EGFR)激酶或磷酯酰肌醇 3-激酶(PI-3K)的抑制作用可消除 ET-1 诱导的电流,表明这些激酶处于下游。关于上游事件,通过渗透肿胀或血管紧张素 II(AngII)激活 I(Cl,swell)被 ET(A)阻断所抑制,而 AngII AT(1)受体阻断未能改变 ET-1 诱导的电流。NADPH 氧化酶(NOX)产生的活性氧物质(ROS)刺激 I(Cl,swell)。不出所料,NOX 阻断抑制了 ET-1 诱导的 I(Cl,swell),但用鱼藤酮阻断线粒体 ROS 产生也抑制了 I(Cl,swell)。用抗霉素 A 或二氮嗪增强复合物 III ROS 产生激活 I(Cl,swell);在这种情况下,I(Cl,swell)对 NOX 抑制剂不敏感,表明线粒体位于 NOX 之后。通过流式细胞术测量 HL-1 心肌细胞中的 ROS 生成证实了电生理发现。NOX 或线粒体复合物 I 的阻断抑制了 ET-1 诱导的 ROS 生成,而复合物 III 诱导的 ROS 生成对 NOX 阻断不敏感。
ET-1-ET(A)信号通过 EGFR 激酶、PI-3K 和 NOX ROS 产生激活 I(Cl,swell),从而引发线粒体 ROS 产生。当 I(Cl,swell)由渗透肿胀或 AngII 引发时,ET(A)受体是下游效应物。这些数据表明,ET-1 诱导的 ROS 依赖性 I(Cl,swell)可能参与多种生理和病理生理过程。